HomeLABFF • OTCMKTS
add
Laboratorios Farmaceuticos ROVI SA
Previous close
$65.86
Year range
$90.61 - $90.61
Market cap
3.29B EUR
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 159.70M | -10.36% |
Operating expense | 77.92M | 6.52% |
Net income | 21.64M | -26.37% |
Net profit margin | 13.55 | -17.83% |
Earnings per share | — | — |
EBITDA | 31.08M | -23.43% |
Effective tax rate | 19.24% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.69M | 5.71% |
Total assets | 869.60M | 1.43% |
Total liabilities | 294.89M | -21.27% |
Total equity | 574.72M | — |
Shares outstanding | 51.15M | — |
Price to book | 5.98 | — |
Return on assets | 8.13% | — |
Return on capital | 9.69% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 21.64M | -26.37% |
Cash from operations | 9.18M | -35.37% |
Cash from investing | -12.38M | -29.29% |
Cash from financing | 19.81M | -26.26% |
Net change in cash | 16.81M | -46.63% |
Free cash flow | 36.92M | -52.16% |
About
Founded
1946
Website
Employees
2,188
